Professional Documents
Culture Documents
NO PREVIOUS
NO KNOWN NO KNOWN
COVID-19
COMORBIDS ALLERGY
INFECTION
No previous Food or medication
hospitalization Fully vaccinated
or surgery Primary: Sinovac
Booster: Moderna x 1 dose
(May 2022)
FAMILY SOCIAL
HISTORY HISTORY
HYPERTENSION NONSMOKER
Both parents
OCCASIONAL
ALCOHOLIC
BEVERAGE DRINKER
PHYSICAL EXAM
INITIAL VS 130/90mmHg > 90bpm > 19cpm > 36.6C > 98% at room air
TEA-COLORED BILATERAL
URINE THIGH
TENDERNESS
RHABDOMYOLYSIS
PRIMARY IMPRESSION
✓ tea-colored urine
NEPHROLITHIASIS ✗ flank pain, dysuria, urgency, nausea/vomiting, CVA
tenderness
✓ tea-colored urine
POST-STREPTOCOCCAL
✗ no recent URTI or skin infection, fever,
GLOMERULONEPHRITIS cough/colds, hypertension, edema
DIFFERENTIAL DIAGNOSES
GI
✓ tea-colored urine
HEPATITIS ✗ fever, nausea/vomiting, jaundice, abdominal pain,
clay-colored stools
✓ tea-colored urine
CHOLEDOCHOLITHIASIS ✗ RUQ/epigastric pain, nausea/vomiting, clay-colored
stools, jaundice, RUQ/epigastric tenderness
OTHERS
✓ NSAIDs (ibuprofen, naproxen)
MEDICATION-INDUCED
✗ nitrofurantoin, metronidazole, chloroquine,
TEA-COLORED URINE
primaquine
DIAGNOSTICS
Total CK (CK-MM, CK-MB)
Urinalysis
CBC
Crea, BUN, Uric acid
Na, K, Ca, Phosphorus
SGPT, SGOT
LABORATORY RESULTS
LABORATORY RESULTS
LABORATORY RESULTS
MANAGEMENT
Volume Urinary
administration alkalinization
Insert IV access Sodium Bicarbonate 150meqs
Hydrate with PNSS in 1L D5W to run at 200mL/hr
initially to run at 1-2L/hr or 650mg/tab 1 tab 3x/day
then titrate according to
volume status and urine
output (200-300mL/hr)
Monitoring
Crea, Urinalysis
Total CK (CKMM, CKMB)
CASE
DISCUSSION
RHABDOMYOLYSIS
ETIOLOGY
● Traumatic or muscle compression
○ Crush syndrome
○ Prolonged immobilization
● Nontraumatic exertional
○ Marked exertion in untrained individuals
○ Eccentric exercises
○ Hyperthermia
● Nontraumatic non-exertional
○ Drugs (statins) or toxins
○ Infections
○ Electrolyte disorders
PATHOPHYSIOLOGY
● Direct myocyte injury or ATP depletion →
dysfunction of Na+/K+ ATPase and Ca2+
ATPase pumps (myocyte integrity) →
myocyte injury → release of intracellular
muscle components (CK, myoglobin (heme),
various electrolytes) → increase in
intracellular Ca2+ → activation of proteases,
increased skeletal muscle contractility,
mitochondrial dysfunction, production of
ROS → skeletal muscle cell death
CLINICAL MANIFESTATION
Nausea/ vomiting
Abdominal pain Malaise, fever,
tachycardia
Muscle pain,
stiffness/cramping
Dark urine
Proximal muscle groups -
thighs, calves,
shoulders, lower back
COMPLICATIONS
● Fluid and electrolyte abnormalities
○ Hypovolemia
○ Hyperkalemia,hyperphosphatemia,
hypocalcemia, hyperuricemia
○ Metabolic acidosis
● Acute kidney injury
● Compartment syndrome
REFERENCES